PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.00%
Positive revenue growth while AVGO is negative. John Neff might see a notable competitive edge here.
2.44%
Gross profit growth similar to AVGO's 2.42%. Walter Schloss would assume both firms track common industry trends.
7.81%
EBIT growth above 1.5x AVGO's 4.24%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
7.81%
Operating income growth above 1.5x AVGO's 4.24%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-6.26%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-3.33%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-8.33%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.16%
Share reduction while AVGO is at 1.18%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.03%
Diluted share reduction more than 1.5x AVGO's 2.16%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
1.66%
Dividend growth under 50% of AVGO's 9.94%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-36.25%
Negative OCF growth while AVGO is at 37.84%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-39.52%
Negative FCF growth while AVGO is at 52.35%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
116.05%
10Y revenue/share CAGR under 50% of AVGO's 311.92%. Michael Burry would suspect a lasting competitive disadvantage.
39.07%
5Y revenue/share CAGR under 50% of AVGO's 189.10%. Michael Burry would suspect a significant competitive gap or product weakness.
16.87%
3Y revenue/share CAGR under 50% of AVGO's 164.54%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
397.76%
10Y OCF/share CAGR at 50-75% of AVGO's 733.23%. Martin Whitman might fear a structural deficiency in operational efficiency.
-30.22%
Negative 5Y OCF/share CAGR while AVGO is at 431.83%. Joel Greenblatt would question the firm’s operational model or cost structure.
26.45%
3Y OCF/share CAGR under 50% of AVGO's 197.17%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
2133.69%
Net income/share CAGR above 1.5x AVGO's 1020.43% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
219.01%
5Y net income/share CAGR at 75-90% of AVGO's 252.59%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
-9.05%
Negative 3Y CAGR while AVGO is 142.79%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
251.20%
10Y equity/share CAGR at 50-75% of AVGO's 344.38%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
87.57%
Below 50% of AVGO's 212.18%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
25.69%
Below 50% of AVGO's 77.23%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
18.46%
AR growth well above AVGO's 5.57%. Michael Burry fears inflated revenue or higher default risk in the near future.
-1.49%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.01%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
3.47%
Under 50% of AVGO's 10.63%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
0.44%
We have some new debt while AVGO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
0.86%
R&D dropping or stable vs. AVGO's 6.81%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
0.08%
We expand SG&A while AVGO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.